The vaccine is personalized to a patientβs tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Although the case is considered exceptional, investigators are working to determine how the infection occurred and whether the pathogen played a role in the patientβs death.
Though plastic is usually inert, tiny pieces of it have the potential to react with one of the most pervasive molecules in the environment and in our bodies.